{
 "PrintNo":"A3903","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-01-28T15:33:59.096023Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2021-01-28","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO INSURANCE","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[
  {"ID":1238,"Name":"Joe DeStefano","Short":"DESTEFANO"},{"ID":1250,"Name":"John Salka","Short":"SALKA"},
  {"ID":1245,"Name":"Mike Reilly","Short":"REILLY"},{"ID":1258,"Name":"Nader Sayegh","Short":"SAYEGH"}
 ],
 "Title":"Prohibits co-pays for certain short term opioid drug prescriptions",
 "Summary":"Prohibits insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription which was initially written for seven days or less.",
 "LawSection":"Insurance Law","LawCode":"Amd ยง3216, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to prohibiting insurance companies from imposing a co-pay pursuant to a follow up visit with a physician in order to receive a refill on an opioid drug prescription",
 "SameAsPrintNo":"S3497-2021","PreviousVersions":["A10435-2015","A3528-2017","A6139-2019"]
}